BusinessWeek says the writing is on the wall:
Bye-bye Big Pharma sales rep. A host of forces is now converging to clamp down on hard-driving, gift-toting pharmaceutical pitchmasters who have been ambushing physicians for the last decade. Doctors, consumer groups, and government regulators have all had enough. And now, pharma CEOs are questioning whether the hard sell even pays off. On Jan. 22, Pfizer Inc. announced unprecedented layoffs. As part of an effort to cut $2 billion in costs by the end of 2008, and to adjust to the loss of patents on several blockbusters, it plans to eliminate 7,800 jobs across the board, including 20% of the European sales force. That’s on top of the 2,200 U.S. salespeople who were let go in November.
(via PharmaGossip)
Related posts:
- Pharmaceutical sales reps on MySpace
- "Pity the poor pharmaceutical sales rep"
- Is Gardasil’s recent bad PR helping sales?
- Drug marketing: "You’re going to get sales forces that resemble sales forces selling beer or pantyhose"
- Drug company ethics and the pharmaceutical industry’s pursuit of profit
- Bad time to be a drug rep
- DTC pharmaceutical advertising
KevinMD.com on Facebook
Comments on this entry are closed.